INMAZEB Trademark

Trademark Overview

On Thursday, December 5, 2019, a trademark application was filed for INMAZEB with the United States Patent and Trademark Office. The USPTO has given the INMAZEB trademark a serial number of 88716277. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The INMAZEB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of Ebola virus infections; antivirals
inmazeb

General Information

Serial Number88716277
Word MarkINMAZEB
Filing DateThursday, December 5, 2019
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6503050
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment or prevention of Ebola virus infections; antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code005
First Use Anywhere DateWednesday, July 28, 2021
First Use In Commerce DateWednesday, July 28, 2021

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, August 26, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 25, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 13, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 4, 2021USE AMENDMENT FILED
Friday, August 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 4, 2021TEAS STATEMENT OF USE RECEIVED
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 14, 2021SOU EXTENSION 2 FILED
Wednesday, April 14, 2021TEAS EXTENSION RECEIVED
Saturday, October 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 22, 2020SOU EXTENSION 1 GRANTED
Thursday, October 22, 2020SOU EXTENSION 1 FILED
Thursday, October 22, 2020TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Wednesday, December 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 9, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

inmazeb virus infections antivirals ebola prevention preparations treatment pharmaceutical